Protalix Biotherapeutics Inc (PLX) has fallen 7.32% Monday In Premarket Trading

Protalix Biotherapeutics Inc (PLX) is lower by Monday morning, with the stock decreasing -7.32% in pre-market trading to 1.52. PLX's short-term technical score of 55 indicates that the stock has traded more bullishly over the last month than 55% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, the stock ranks higher than 77% of stocks. Protalix Biotherapeutics Inc has fallen 7.87% over the past month, closing at $1.75 on September 11. During this period of time, the stock fell as low as $1.56 and as high as $1.85. The company has an average price target of $16.00.

PLX has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on PLX!

See Full PLX Report

Protalix Biotherapeutics Inc has a Long-Term Technical rank of 46. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 54% of the market scoring higher. In the Biotechnology industry which is number 135 by this metric, PLX ranks better than 135% of stocks.

Important Dates for Investors in PLX:

-Protalix Biotherapeutics Inc is set to release earnings on 2023-11-13. Over the last 12 months, the company has reported EPS of $0.01. -We do not have a set dividend date for Protalix Biotherapeutics Inc at this time. Click Here To Get The Full Report on Protalix Biotherapeutics Inc (PLX)